Picture of Bausch + Lomb logo

BLCO Bausch + Lomb Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedLarge CapTurnaround

Annual income statement for Bausch + Lomb, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue3,7653,7684,1464,7915,101
Cost of Revenue
Gross Profit2,2982,2492,5042,9193,051
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,4363,5614,0164,6294,994
Operating Profit329207130162107
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes31873-166-234-317
Provision for Income Taxes
Net Income After Taxes19315-248-305-352
Minority Interest
Net Income Before Extraordinary Items
Net Income1826-260-317-360
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1826-260-317-360
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.5430.091-0.588-0.802-0.836
Dividends per Share